In neuroblastoma (NB), MYCN-induced upregulation of the H3K9 methyltransferases G9a and GLP as well as EZH2 can also inhibit IFN-γ-induced expression of CXCL9 and CXCL10 [149]. Here, EZH2 is linked to neuroblastoma.